Evidence map›Paper›PMID 42078355›Full record

ArticlemedRxiv : the preprint server for health sciences2026

Coregulated metabolite networks associated with global protein crotonylation are central pathophysiological processes in prediabetes and diabetes.

Dhruv Dubey, Tumpa Dutta, Anna Casu, Anton Iliuk, Stephen J Gardell, Richard E Pratley, Yury O Nunez Lopez

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Dhruv DubeyJohns Hopkins University, Baltimore, ML 21218, USA.
Tumpa DuttaAdventHealth Translational Research Institute (TRI), Orlando, FL 32804, USA.ORCID 0000-0003-0400-209X
Anna CasuAdventHealth Translational Research Institute (TRI), Orlando, FL 32804, USA.ORCID 0000-0001-6924-0617
Anton IliukTymora Analytical Operations, West Lafayette, Indiana 47906, USA.ORCID 0000-0002-2914-1363
Stephen J GardellAdventHealth Translational Research Institute (TRI), Orlando, FL 32804, USA.ORCID 0000-0002-3798-8230
Richard E PratleyJohns Hopkins University, Baltimore, ML 21218, USA.ORCID 0000-0002-2912-1389
Yury O Nunez LopezAdventHealth Translational Research Institute (TRI), Orlando, FL 32804, USA.ORCID 0000-0003-0382-9124

Funding

Revision to the Coordinating Center for Type 1 Diabetes TrialNetU01DK106993 · NIDDK · UNIVERSITY OF SOUTH FLORIDA · PI JEFFREY P KRISCHER, SAMUEL S WU · 2019 to 2026
$181.3M
Ketone Monitoring Approaches for DKA Risk Mitigation in People with T1D on Adjunctive SGLT2 Inhibitors (KARMA)U01DK143384 · NIDDK · ADVENTHEALTH ORLANDO · PI PRATLEY, RICHARD E, TAYLOR, SIMEON I. · 2025 to 2025
$2.5M
Care partner-assisted ImplementatiOn of Patch HybrId Closed Loop Insulin Delivery for Older Adults with T1D (COPILOT)R01DK143524 · NIDDK · JAEB CENTER FOR HEALTH RESEARCH, INC. · PI HENDERSON, ROBERT J, KUDVA, YOGISH C. · 2025 to 2025
$2.3M
Advanced Insulin Delivery to Reduce Impaired Awareness of Hypoglycemia in a T1D Cohort (AIDRIAHT1C)U01DK135131 · NIDDK · ADVENTHEALTH ORLANDO · PI Anna Casu, RICHARD E PRATLEY · 2022 to 2026
$2.3M
Diabetes RElated to Acute Pancreatitis and its Mechanisms: Metabolic Outcomes Using Novel CGM Metrics (DREAM-ON)R01DK138060 · NIDDK · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI Vernon M Chinchilli, RICHARD E PRATLEY · 2024 to 2026
$2.3M
Type 1 Diabetes in Acute Pancreatitis Consortium - Clinical CentersU01DK127392 · NIDDK · UNIVERSITY OF FLORIDA · PI CHRISTOPHER E FORSMARK, STEVEN J HUGHES · 2020 to 2026
$1.9M
NIDDK NIH HHS R01 DK138060NIDDK NIH HHS R01 DK143524NIDDK NIH HHS U01 DK106993NIDDK NIH HHS U01 DK127392NIDDK NIH HHS U01 DK135131NIDDK NIH HHS U01 DK143384
6 · The paper itself

Abstract

Type 2 diabetes and prediabetes affect hundreds of millions of people globally, yet the metabolic networks underlying disease development remain poorly understood. Using untargeted liquid chromatography-mass spectrometry (LC-MS/MS), we profiled a total of 15,470 (900 known) serum metabolite features across the human diabetes spectrum (the most comprehensive coverage reported to date). Weighted coexpression network analysis of samples from people with normal glucose tolerance, prediabetes, and type 2 diabetes, collected at baseline and 2 hours after an oral glucose tolerance test, revealed tightly coregulated modules strongly associated with glycemic dysregulation, insulin resistance, and islet dysfunction. Notably, short-chain organic acids, particularly crotonic acid, emerged as hubs of the diabetes-associated networks, accumulating progressively with disease severity. Reanalysis of extracellular vesicle proteomics from the same cohort showed that 16.5% of circulating proteins were crotonylated, with 47.6% correlated with crotonic acid and other hub metabolites, establishing a metabolome-crotonylome axis as a novel mechanism in diabetes development.

Identifiers

PMID42078355
PMCPMC13131736

What OpenQuestion holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.